![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEisMEdHkY3cvJDjMCqwAe_l-rd7hiJfktbE9lHn78GXWqk7L_gAJJ71T9gUjDB58mjOrtn_oNZLlTcBqfzwbthtq99Nmq8twpdKQcn4u-j7TKPBPi-RUsT8SxPA6mUVZq4OottXH5_JsuU/s200/scanner.webp)
Adebayo Samuel Alonge has broken records to become the first African to win the award for best innovation in the world largest conference of DeepTech Scientists. The graduate of Pharmacy from the University of Ibadan, Nigeria and the CEO of RxAll Inc. (a firm that uses Deeptech or artificial intelligence to check the quality of drug), became the first African to win such an award in the just concluded DeepTech conference that held in Paris, France, winning the sum of €100,000, after developing a handheld scanner that uses nanotechnology to detect fake drugs. He emerged the best after competing against over 4,500 participants from all over the world.
DeepTech refers to a fundamental breakthrough in science and engineering that profoundly impacts industries and people's lives by giving solutions to pre-existing problems. Adebayo in his presentation stated that up to 70% of drugs in Africa are fake. This is surely a breakthrough in the pharmaceutical industry in Africa especially in countries like Nigeria where open drug market system is still a problem. Adebayo believes that more African can be involved in Deeptech with the right environment and support as most of his training was in Nigeria.